Skip to main content

Rohit
Ramchandani

Associate
Dr. Ramchandani Headshot

Departmental Affiliations

Affiliated
Division
Global Disease Epidemiology and Control

Center & Institute Affiliations

Rohit Ramchandani, DrPH, MPH, is an award-winning researcher, innovator, and business executive specializing in health innovation, with current areas of focus including psychedelic-medicine & childhood diarrhea.

Contact Info

Research Interests

Health Innovation; Health Systems Strengthening; Behavioural Science & Human-Centred Design; Scaling; Monitoring & Evaluation (M&E); Global Mental Health & Psychedelic Medicine; Childhood Diarrhea; Tuberculosis; Malaria; Blindness/Vision Sciences; Pandemic Preparedness & Response; Implementation Science; Health Delivery; Multi-Sectoral Partnerships; WASH; One Health; Access & Equity.

Experiences & Accomplishments
Overview

Rohit Ramchandani, DrPH, MPH is an accomplished researcher, educator, business executive and implementation scientist. For almost two decades, Dr. Ramchandani's research and practice has focused on the conceptualization, design, development, implementation, evaluation and scaling of health innovations with the potential for broad scale population health impact. With a systems lens, and working at the intersections of multiple sectors (public, private, NGO, academia, civil society), he has played key leadership roles across multiple life-saving intervention programs and projects (e.g. childhood diarrhoea, WASH, malaria, tuberculosis, One Health, COVID-19, psychedelic medicine for mental health). He has taught courses and runs workshops on global health innovation. He regularly sits on thesis committees and advises students. He, and projects he has led, are recipients of numerous awards including the FT/IFC Transformational Business Award in Health, London Design Museum's Product Design of the Year, JHSPH's Georgeda Buchbinder Research Award, the University of Waterloo's Young Alumni Award, a Grand Challenges Canada Rising Stars in Global Health Award, and the Canada Millennium Excellence Scholarship. He holds faculty appointments within the Bloomberg School of Public Health, The University of Waterloo School of Public Health Sciences, and is a Fellow at the Balsillie School of International Affairs. As a member of the Board of Directors of the Jane Goodall Institute, he focuses on improving the intersections between animals, people and the environment. Dr. Ramchandani is also an Alumnus of esteemed programs including the Governor General's Canadian Leadership conference, the AKFC Global Leadership Program, and SHAD Valley. In addition to his academic roles, he is currently Chief Innovation Officer at Huxley Health and the Institute for Psychedelic-Assisted Therapies & Healing (IPATH).

Honors & Awards

2019 - Selected as a Kick Ass Canadian (http://kickasscanadians.ca/) along with astronaut Chris Hadfield and Olympian Clara Hughes

2015 - INDEX Award: Design to Improve Life, Finalist (top 4%)

2015 - GlaxoSmithKline (GSK)/Save the Children Healthcare Innovation Award (“Oscars of Healthcare Innovation”)

2014 - Financial Times (FT)/International Finance Corporation (IFC) Transformational Business Award – Health Category

2013 - Winner of the Diamond Award (Top Award) and the Food Security Award at the 25th Dupont Packaging Innovation Awards

2013 - Observer Ethical Product of the Year Award (for the Kit Yamoyo anti-diarrhea kit)

2013 - ColaLife's innovation, diarrhoea treatment co-pack, is highlighted as a “Best Buy in Global Health”. Impact Magazine. Retrieved from: https://issuu.com/mandy_mac/docs/psi_impact_no16_loresmarch21__1_

2013 - Highlighted at the UN General Assembly for selection as one of "10 Breakthrough Innovations in Child Health" (for the Kit Yamoyo anti-diarrhea kit) – PATH and the Every Woman, Every Child Initiative

2013 - International Product Design of the Year (for the Kit Yamoyo anti-diarrhea kit) - London Design Museum

2012 - Selected as member of the Governor General’s Canadian Leadership Conference (GGCLC) for Top Canadian Leaders across all sectors

2012 - Top 5% Most Viewed LinkedIn Profiles of 2012 

2012 - Grand Challenges Canada Rising Stars in Global Health Award recipient (as Principal Investigator for the ColaLife Operational Trial Zambia)

2011 - Georgeda Buchbinder Research Award, Johns Hopkins School of Public Health

2009 - Young Alumni Award, Faculty of Applied Health Sciences, University of Waterloo

2007 - Celebrating Performance Award, Accenture Health and Life Sciences

2005 - Volunteer of the Year, Unite For Sight

2004 - University of Waterloo John McBain Award for International Entrepreneurship

2000-2004 - Canada Millennium Excellence Award (National Laureate)

2000 - Vedic Cultural Scholarship - outstanding contribution to the South Asian Community

1999 - University of British Columbia Shad Valley Program + Royal Bank Shad Entrepreneurship Cup – Best Business Plan

Select Publications

Selected Publications:

Projects
Executing an innovation process focused on delivering the benefits of evidence-based psychedelic-assisted therapy at scale
Principal Investigator and Public Health Advisor of the globally renowned ColaLife model, transforming access to ORS and Zinc for childhood diarrhoea
Advisor to Secretariat of the Independent Panel on Pandemic Preparedness & Response (IPPPR); leading assessment on health systems/pandemic response for critical products: Tx, Dx, Vx, PPE; Client: WHO
Led study on global health product R&D systems with focus on product development partnerships (PDPs), including for poverty-related and neglected disease vaccines, therapeutics and diagnostics; Client: FCDO (DFID) & PDP Funders
Led sampling strategy for national Lot Quality Assurance Sampling (LQAS) health survey in South Sudan; Client: DFID/Crown Agents
Assessed how the private sector in Zambia could be better leveraged to improve access to sexual and reproductive health (SRH) and HIV-related products and services; Client: USAID
Led summative evaluation for the Improving Nutrition for Mothers, Newborns and Children (INMNC) program in Afghanistan in line with Canada’s Feminist International Assistance Policy (FIAP); Client: Global Affairs Canada
Led summative evaluation for the Maternal and Under-5 Nutrition and Child Health Project (MUNCH) in Afghanistan; Client: Global Affairs Canada
Lead external monitor (w Alinea International) for Grand Challenges Canada (GCC), focusing on its maternal and child health and mental health innovations portfolios; Assessing processes/impact of health innovations; Client: Global Affairs Canada
Strategic direction on WHO’s Youth Engagement Strategy, focused on engagement of young people within the context of the Sustainable Development Goals (SDGs), culminating in the development of a new WHO publication launched at UNGA 2018
Led the evaluation of DFAT Australia’s $40M investment in Product Development Partnerships focusing on Medicines for Malaria Venture, the Fund for Innovative New Diagnostics, and TB Alliance; Developed options & key recommendations for further investments
Established framework for client’s role as manager of PEPFAR’s DREAMS Innovation Challenge, focused on prevention of HIV in adolescent girls; Client: Johnson & Johnson
Developed key recommendations, based on OECD-DAC criteria, for program improvement as Senior Health Evaluation Specialist for Aga Khan Foundation’s Central Asia Health Systems Strengthening Initiative (Afghanistan, Tajikistan, Kyrgyz Republic, Pakistan)
Developed multi-sectoral partnership and evidence-based strategy to improve health of garment factory workers in Southeast Asia, with emphasis on TB; Client: Johnson & Johnson
Provided key insights and public health advice relating to Canada’s G8 Maternal and Child Health (MCH) Initiative launch programs and framework
Developed Treasury Board Submission and co-developed innovative financing concept for a multilateral tuberculosis program (TB REACH Facility) that resulted in Government of Canada commitment of $120M in new funding for tuberculosis detection and control
Managed and led Canadian participation on the Affordable Medicines Facility – malaria (AMFm); represented Global Fund constituency of Canada, Germany and Switzerland; advocated for reaching the poor as Co-Chair of the Equity Working Group
Represented Canadian International Development Agency's interests on the Government of Canada’s Global Health Research Initiative (GHRI) Steering Committee; helped develop strategic directions for this global health research funding partnership
Evaluated, measured and analyzed public sector value and productivity within the Ontario Health System and coordinated a policy development process for a Director-level working group; Client: Ontario Ministry of Health
Worked with large hospital network to help develop provincial strategy for reducing wait times in 5 key surgical areas; Client: University Health Network
Managed project financials, key deliverables, and vendor relations for a large-scale Provincial Laboratory Information System that allows for e-sharing of laboratory results throughout Ontario; Client: Ontario Ministry of Health
Conducted project management activities for Enterprise Resource Planning (ERP) implementation at large global pharmaceutical company
Managed a team of three while on WHO internship through the LV Prasad Eye Institute’s International Center for the Advancement of Rural Eye Care
Investigation of the Role of Lamina Cribrosa Biomechanics and Ischemia in Glaucomatous Optic Neuropathy; University Health Network, Toronto Western Hospital & UW School of Optometry